-
Review: China's paint market development in 2014 presents three kinds of situations
Time of Update: 2021-03-09
by 0.6 percentage points. Residential investment accounted for 67.8% of real estate development investment. review of the overall trend of domestic real estate industry investment in 2014, we issued in 2014 China's real estate industry
-
2015 developer preferred supplier brand review enterprise: Wilda
Time of Update: 2021-03-09
. On January 29th, the first procurement executive review was launched in Shanghai. 2014-2015 top 500 developers preferred supplier project performance declaration - Verda enterprise introduction: Sichuan Verda Energy Saving
-
TOP3 hemostotting drug injections are selling out to shock the first review
Time of Update: 2021-03-09
of the product, Bett is expected to impact the first review. Figure 1: Chengdu Ptot Pharmaceuticals' ammonia cyclic acid injection registration source: CDE official website Figure 2: Sales of amino acid Source: Minet China's public medical institutions
-
Nexpovio, the first nuclear output inhibitor, is about to be approved for review by China
Time of Update: 2021-03-09
Selinexor is the world's first oral selective nuclear output inhibitor (SINE), approved in the United States under the name Xpovio, for the treatment of the hematoma field's two major adaptors - multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL).
-
It's sunny! Take 5 more than $1 billion imitation 32 over-reviewed varieties bright...
Time of Update: 2021-03-09
10 heavy-duty new products (including 6 first imitations), 3 new drugs applied for market (including 1 new class 1 drug), 9 innovative drugs approved clinically (including 6 new class 1 drugs). At present, the company has 32 varieties over
-
Yangzijiang, Fosun, sunny... 13 product line reviews
Time of Update: 2021-03-09
of competition is extremely fierce, a new round of price war is about to start. Table 1: Reviewed after January 15, 2021 / As same as the evaluation of the product situation (by status start time statistics) Source: Minet 2.0MED China Drug Review
-
The application for listing of Trotsip for the injection of Baishi Meishiguibao was accepted for priority review
Time of Update: 2021-03-08
for adult patients with β-thalassemia who need regular infusions of red blood cells (RBC). BMS press release, this is the company's first innovative blood disease drug to be included in the priority review after submitting data from offshore
-
External JAK inhibitor to treat eczema Incyte using priority review vouchers submitted...
Time of Update: 2021-03-07
Retrieved February 19, 2021, from Ruxolitinib Cream: Phase 3 Data in Atopic Dermatitis.
-
Coating service provider Science and Technology has entered the ranks of the new three-board review
Time of Update: 2021-03-07
China Coatings Network : Coating service provider Guangdong Science and Technology Co., Ltd. (hereinafter referred to as "Kofu Technology") officially entered the ranks of the new three-board review. reporter learned that in 2011
-
Environmental reviews of coal chemical projects are tightening
Time of Update: 2021-03-07
chemical industry. Chen Bin, a professor at Beijing Normal University's School of The Environment, read the news in an interview with the China Chemical News. He believes that the government has begun to learn lessons, China's environmental review of coal
-
Review of the EU 2020 PRIME Priority Medicines Program
Time of Update: 2021-03-07
to be reviewed under the EMA's accelerated evaluation mechanism. this means that fast tracks are not established and it is not uncommon for products through PRIME to be reviewed within the standard time range. 84 determinations have been
-
FDA responds to criticism of Alzheimer's drug review process by refusing to pre-declaration and claim...
Time of Update: 2021-03-07
, Public Citizen, a consumer advocacy group, issued a scathing letter of criticism about the FDA's review process for Biogen's controversial Aducanumab listing, saying that Billy Dunn, director of the Office of Neuroscience, and other reviewers had
-
2020 Domestic CRO Industry Review
Time of Update: 2021-03-06
key materials to fight the outbreak include testing reagents, vaccines, drugs, and some medical devices, and research and development and production units are working overtime, with CRO companies that can provide supporting services.
-
Scientists find wheat "cancer" star Yuan Long equal review
Time of Update: 2021-03-06
of which are quite resistant. Niu Jishan, an associate researcher at the National Wheat Engineering Center of Henan Agricultural University, and others mentioned in the study review that the genetic background had an effect on the resistance of Fhb1
-
3 new drugs to be included in the priority review!
Time of Update: 2021-03-06
Supi Medicine's new rare disease drug Nitesinon capsules, the proposed development of adaptive disorders are: combined with tyrosine and phenylalanine dietary restrictions, for the treatment of adult and pediatric patients (at any age) hereditary HT-1.
-
AstraZeneta's Tagrisso gets FDA priority review
Time of Update: 2021-03-06
AstraZeneca's EGFR tyrosine kinase inhibitor Tagrisso has been given priority review by the U.S. Food and Drug Administration (FDA) to treat lung cancer with early EGFR mutations. In particular, AstraZenecom
-
Tiger Pharma will achieve revenue of 2.8 billion yuan in 2019
Time of Update: 2021-03-06
Tiger Pharma said the increase in revenue from its domestic business during the reporting period was mainly due to an increase in the proportion of in-country innovative pharmaceutical clinical trials.
-
Fosun Pharma withheld a net profit of 2.2 billion yuan in 2019
Time of Update: 2021-03-06
In the medical services business, Fosun Pharma achieved operating income of 3.040 billion yuan in 2019, an increase of 18.61 percent over 2018.
-
Jingfeng Pharmaceuticals is expected to lose 850 million yuan in 2019
Time of Update: 2021-03-06
555.00% to 447.94 percent from a year earlier. Jingfeng Pharmaceuticals said that in 2019, in the drug bidding price reduction, the state focus on monitoring the introduction of rational drug use drug catalog, "4 plus 7" drug
-
Time is ahead again! An Italian woman has been infected with the new coronavirus in November 2019
Time of Update: 2021-03-06
An international research team led by the University of Milan in Italy found the genetic sequence of the new coronavirus from a biopsy sample taken by a young female dermatology patient in the country on November 10, 2019, an Italian media outlet
